Form 4 for ARDX ARDELYX, INC.
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-20 · accession 0001628280-24-049057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-22 | 2024-11-20 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $4.79 | -7,366 | 308.7K | -2% | -$35.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-20 | S | D | 7,366 | $4.79 | 308,745 | D | — | — | (F2) Reflects the adjusted total which includes the purchase of 1,371 shares under the Ardelyx Employee Stock Purchase Plan in August 2024. |